VRDN (STOCKS)
Viridian Therapeutics, Inc. Common Stock
$19.560000
+1.180000 (+6.42%)
Prev close: $18.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Stephen Frank Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,216.00M
- Employees
- 143
- P/E (TTM)
- -4.96
- P/B (TTM)
- 3.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
14
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.05 | $-1.05 | -0.0001 | -0.01% |
|
Mar 2026 (Q1)
|
$-0.90 | $-1.12 | +0.2162 | +19.37% |
|
Dec 2025 (Q4)
|
$-1.08 | $-1.09 | +0.0105 | +0.96% |
|
Sep 2025 (Q3)
|
$-0.34 | $-1.10 | +0.7644 | +69.21% |